Risk Warning

Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong. 

NOT FOR RETAIL CLIENTS – The information contained on this website is solely intended for professional investors, defined as investors who (1) qualify as professional clients within the meaning of the Markets in Financial Instruments Directive II (MiFID II) or (2) have requested to be treated as professional clients within the meaning of MiFID II.

access beyond

FUTURE-PROOF IMPACT INVESTING

Age related medical conditions account for over 60% of all loss of human life

Selvedge Venture invests into founders and start ups with a mission to allieviate the titanic healthcare burden caused by age-related medical conditions. We invest into Pre-Seed, Seed and Series A ready companies

We focus on three age related medical conditions

Metabolic Syndrome (Cardiovascular Disease, Diabetes, Fatty Liver Disease and Obesity), Cancer and Neurodegenerative Diseases. Each of these conditions accounts for a huge burden of both excess deaths and healthcare spend

Leveraging Biotechnology, Machine Learning Tools and Integrated Data Assets

Selvedge Venture’s core expertise is at the intersection of Biotechnology and Digital Technologies. Recent advances in the state of the art of both of these technologies provide a platform to shape healthcare and life sciences for many years to come

SELECTED PORTFOLIO COMPANIES

Alasdair Thong

FOUNDING PARTNER

Robert Thong

CO-FOUNDER & GENERAL PARTNER

meet the team

Risk Warning

Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong. 

NOT FOR RETAIL CLIENTS – The information contained on this website is solely intended for professional investors, defined as investors who (1) qualify as professional clients within the meaning of the Markets in Financial Instruments Directive II (MiFID II) or (2) have requested to be treated as professional clients within the meaning of MiFID II.